Landscape Capital Management L.L.C. grew its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 446.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,996 shares of the company's stock after buying an additional 10,619 shares during the period. Landscape Capital Management L.L.C.'s holdings in Cardinal Health were worth $1,537,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in CAH. Cyrus J. Lawrence LLC bought a new stake in shares of Cardinal Health during the 4th quarter valued at about $26,000. Promus Capital LLC acquired a new stake in shares of Cardinal Health during the 4th quarter worth approximately $30,000. Lee Danner & Bass Inc. bought a new stake in shares of Cardinal Health in the 4th quarter worth approximately $35,000. Kentucky Trust Co bought a new stake in Cardinal Health in the fourth quarter valued at $41,000. Finally, HHM Wealth Advisors LLC boosted its holdings in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after acquiring an additional 144 shares during the period. 87.17% of the stock is currently owned by institutional investors.
Cardinal Health Price Performance
Shares of NYSE:CAH traded down $3.55 on Thursday, reaching $126.90. 1,187,016 shares of the company traded hands, compared to its average volume of 2,164,522. The stock has a market capitalization of $30.65 billion, a PE ratio of 23.86, a P/E/G ratio of 1.49 and a beta of 0.61. The company's 50 day moving average is $129.13 and its 200-day moving average is $122.10. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio is 37.69%.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on CAH. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Bank of America upgraded Cardinal Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Mizuho raised their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. Morgan Stanley upped their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a report on Friday, January 31st. Finally, JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research note on Tuesday, February 4th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $140.14.
View Our Latest Report on CAH
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.